In push for FDA approval, Novan adds Paula Brown Stafford to board

After hiring former Quintiles executive Paula Brown Stafford in March as its chief development officer, Morrisville-based Novan has appointed her to the board of directors. Stafford, who oversaw clinical development before leaving Quintiles in 2015, was recruited to join Novan because of her experience working with the U.S. Food and Drug Administration. That was of particular importance to Novan because its primary acne treatment candidate, SB204, received mixed Phas e 3 trial results– sending…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news